Stocks Comparison
Incyte vs Iqvia: revenue, profit, margins and growth compared
Incyte brought in $5.1B of revenue in fiscal 2025, Iqvia $16.3B in fiscal 2025. Revenue changed by +21.2% at Incyte and +5.9% at Iqvia on the year before, so Incyte grew faster. Incyte kept 25.0% of its revenue as net profit, Iqvia 8.3%.
Side by side, latest fiscal year
| INCY | IQV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $5.1B | $16.3B |
| Revenue growth | +21.2% | +5.9% |
| Net income | $1.3B | $1.4B |
| Net margin | 25.0% | 8.3% |
| Free cash flow | n/a | $2.1B |
| Free cash flow margin | n/a | 12.6% |
| Earnings per share (diluted) | $6.41 | $7.84 |
| Cash | $3.1B | $2B |
| Debt | n/a | $15.7B |
| Price to earnings | 19.3 | 34.5 |
| Market value | $25.1B | $44.5B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #60 of 523 · Health care | #32 of 523 · Health care |
Over the years
INCY $5.1BIQV $16.3B
INCY $1.3BIQV $1.4B
INCY 25.0%IQV 8.3%
INCY +21.2%IQV +5.9%
INCY $892.1MIQV $2.1B
Questions about Incyte and Iqvia
Which is bigger by revenue, Incyte or Iqvia?
Iqvia is bigger by revenue: $16.3B in fiscal 2025, against $5.1B for Incyte in fiscal 2025.
Which keeps more of its revenue as profit, Incyte or Iqvia?
Incyte had a net margin of 25.0% in fiscal 2025; Iqvia had 8.3% in fiscal 2025.
Which grew revenue faster, Incyte or Iqvia?
In their latest fiscal years revenue changed by +21.2% at Incyte and +5.9% at Iqvia.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.